Making medicines affordable

Cipla Chairman Dr Yusuf Hamied donates Rs 8.7 Crore to Royal Society of Chemistry for next leg of Inspirational Science Programme.

geetanjali

Geetanjali Minhas | March 7, 2019 | Mumbai


#Inspirational Science Programme   #Royal Society of Chemistry   #Yusuf Hamied   #licensing   #India   #medicine   #Cipla  
Royal Society of Chemistry in India announces funding boost from philanthropist Dr Yusuf Hamied
Royal Society of Chemistry in India announces funding boost from philanthropist Dr Yusuf Hamied

Calling for a pragmatic and compulsive licensing system in healthcare, chairperson, Cipla, Dr Yusuf Hamied said that government must formalise essential drugs. Making a strong voice for compulsory licensing and voluntary licensing to make medicine affordable, he said that when a multinational company does not give individual license for essential drugs the government should step in, ask for license and give royalty payment. “Science has to be rewarded but not denied,” he said.      

Citing the example of multinational company, Gilead Sciences Inc.– that entered into voluntary licensing agreement against royalty payment for Hepatitis-C drug 'Sofosbovir' which brought down prices for patents in India – he said that out of the world’s 50 top selling drugs, 70 percent are made and marketed by companies that did not invent them and are in-licensed. “India should in-license. With 1.35 billion people in our country who cannot afford monopoly and despite very high malnutrition in India, Vitamin B1, B2, B6 Vitamin D, Vitamin E and Vitamin C are not made in India. We have to be self-reliant and not self-sufficient,” said the renowned scientist and business leader. He was announcing his continued support and expansion of Inspirational Science Programme along with the Royal Society of Chemistry (RSC) in India with a donation of Rs 8.7 crore.
 
The four year programme will train 20,000 teachers covering most regions in India and reach out to 2,400 under privileged students under Salters’ Chemistry Camps. Since its first phase, which started in Bangalore, the Yusuf Hamied Inspirational Chemistry Programme has trained 23,000 science teachers across 9,000 schools in 26 states between 2014 and 2018. More than 1,600 students from 500 schools attended 26 Salters’ Chemistry camps.
 
The four year programme will provide Indian teachers new tools for delivering engaging and effective science lessons and encourage students to reach the necessary standards to study science at university. “A main part of the new programme will be to explore the introduction of three new key enhancements, to translate teacher training content into selected local languages, to develop training modules to cover additional specific disciplines and to explore how mobile access to the Royal Society of Chemistry’s teaching resources could complement the programmes aims. After an exploratory phase, implementation of any additional activities would commence from 2020 onwards,” said Dr. Robert Parker, chief executive of the Royal Society of Chemistry.
 
Speaking to Governance Now Dr Parker said, “Science can be a creative and fulfilling career for children and have benefits for the world. India has massive talent that could be working on inspirational chemistry as we need chemistry developments to make life better – be it in the area of health care, renewable energy or environment. With 23,000 teachers in its first phase, it was three times the original number of teachers we had set out to train. The programme is developed from feedback received by the teachers in India to make it more relevant and suitable for them and the children they are trying to engage with.” 
 
Dr Hameid added that the next programme will be practical in nature and adapt to India’s needs particularly in the area of medicines. “We are toying with the idea to see how chemistry can be taught long distance and asked RSC to expand it into science. Along with science programmes, students will be taught to develop skills and use the knowledge imparted to be more productive. Our next set up with RSC is how we get in technology we don’t have in India to make some older drugs that we are not producing,” he said.  
 

Comments

 

Other News

India’s forest cover increases by 5,516 sq km in four years

The Dehradun-based Forest Survey of India (FSI), an organization under the Ministry of Environment, Forests and Climate Change, carries out the assessment of forest cover biennially since 1987 and the findings are published in the India State of Forest Report (ISFR). As per the latest ISFR 2021, there is a

Steps taken to meet higher power demand of April-May

While the average growth of energy requirement in the country for 2023-24 viz-a-viz 2022-23 has been estimated as 4.9%, the months of April and May have been projected as high demand period. During the current year, the peak demand is expected to be around 229 GW during the summer period. The government ha

Millets to make comeback in army ration after half a century

As the UN has declared 2023 as the International Year of Millets, the Indian Army has steered introduction of millets flour in the rations of soldiers. This landmark decision will ensure troops are supplied with native and traditional grains after over half a century, when these were discontinued in favour

Central Bank Digital Currency has game-changing potential

When discussing digital currency, you might think of one or two well-known varieties. There is the digital representation of currency that you access with mobile and online banking services. This currency is the liability of a commercial bank. There is also cryptocurrency, a digital medium of exchange issu

An Insider’s Account of the Zail Singh Years: The Endgame

The Indian President: An Insider’s Account of the Zail Singh Years By K.C. Singh HarperCollins, 312 pages, Rs.699  

‘My Father Was a Simple Man’: Remembering Gen. Rawat

Bipin: The Man Behind the Uniform By Rachna Bisht Rawat Penguin, 207 pages, Rs 599 On the morning of 8 December 202

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now


Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter